| Bioactivity | (E/Z)-Ozagrel (sodium) [(E/Z)-OKY-046 (sodium)] is an EZ configuration mixture of Ozagrel (sodium) (HY-B0428A). Ozagrel (sodium) is a thromboxane A2 (TXA2) synthase inhibitor. Ozagrel (sodium) is an antiplatelet agent, which selectively inhibits human platelet aggregation with an IC50 of 53.12 μM[1]. |
| CAS | 130952-46-4 |
| Formula | C13H11N2NaO2 |
| Molar Mass | 250.23 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Max Seidy Saito, et al. Antiplatelet pyrazolopyridines derivatives: pharmacological, biochemical and toxicological characterization. J Enzyme Inhib Med Chem. 2016 Dec;31(6):1591-601. |
(E/Z)-Ozagrel sodium
CAS: 130952-46-4 F: C13H11N2NaO2 W: 250.23
(E/Z)-Ozagrel (sodium)is an EZ configuration mixture of Ozagrel (sodium) (HY-B0428A). Ozagrel (sodium) is a thromboxane
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.